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Heidelberg, GermanyABSTRACT Titin is a large filamentous protein that is responsible for the passive force of the cardiac sarcomere. Titin’s force is
generated by its I-band region, which includes the cardiac-specific N2B element. TheN2B element consists of three immunoglob-
ulin domains, two small unique sequence insertions, and a large 575-residue unique sequence, the N2B-Us. Posttranslational
modifications of the N2B element are thought to regulate passive force, but the underlying mechanisms are unknown. Increased
passive-force levels characterize diastolic stiffening in heart-failure patients, and it is critical to understand the underlying molec-
ular mechanisms and identify therapeutic targets. Here, we used single-molecule force spectroscopy to study the mechanical
effects of the kinases calcium/calmodulin-dependent protein kinase II delta (CaMKIId) and extracellular signal-regulated kinase
2 (ERK2) on the single-molecule mechanics of the N2B element. Both CaMKIId and ERK2 were found to phosphorylate the N2B
element, and single-molecule force spectroscopy revealed an increase in the persistence length (Lp) of the molecule, indicating
that the bending rigidity of the molecule was increased. Experiments performed under oxidizing conditions and with a recombi-
nant N2B element that had a simplified domain composition provided evidence that the Lp increase requires the N2B-Us of
the N2B element. Mechanical experiments were also performed on skinned myocardium before and after phosphorylation.
The results revealed a large (~30%) passive force reduction caused by CaMKIId and a much smaller (~6%) reduction caused
by ERK2. These findings support the notion that the important kinases ERK2 and CaMKIId can alter the passive force of
myocytes in the heart (although CaMKIId appears to be more potent) during physiological and pathophysiological states.INTRODUCTIONDuring the diastolic phase of the cardiac cycle, the ventric-
ular chamber fills, cardiac myocytes are stretched, and a
resistive force is developed by the giant protein titin
(1,2). Single molecules of titin span half of each sarcomere,
or contractile unit of muscle, from the Z-disk to the M-band
(3,4). The portion of titin that is located in the I-band re-
gion of the sarcomere contributes greatly to muscle elastic-
ity (5–7). Due to alternative splicing, there are three
different cardiac isoform classes of titin (8,9). The I-band
region of all isoforms contains tandem immunoglobulin
(Ig) segments (serially linked Ig domains), a PEVK
element (rich in proline (P), glutamate (E), valine (V)
and lysine (K)), and the N2B element (10). The N2B
element is cardiac specific and consists of a large 575-res-
idue unique sequence (the N2B-Us), three flanking Ig do-
mains (I24–I26), and two other smaller unique sequences
(21 and 67 residues in size, respectively) (10). Importantly,Submitted September 11, 2015, and accepted for publication November 4,
2015.
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0006-3495/15/12/2592/10the N2B-Us appears to be a hotspot for posttranslational
modifications, and phosphorylation is thought to alter its
mechanical state (11,12). Furthermore, deranged phosphor-
ylation of cardiac titin characterizes heart failure with pre-
served ejection fraction (13–16). This type of heart failure
is highly prevalent, but its molecular basis is not under-
stood (17). Hence, it is important to understand in detail
all of the changes that titin phosphorylation causes in titin’s
spring region.
Protein kinase A (PKA), which is activated by the
b-adrenergic pathway, phosphorylates the large unique
sequence of the N2B element that reduces passive muscle
stiffness (18,19). Similarly to PKA, protein kinase G
(PKG), a cGMP-dependent kinase that is part of signaling
cascades initiated by nitric oxide and natriuretic peptides,
phosphorylates the unique sequence of the N2B element
and reduces passive stiffness. The PKG phosphorylation
site in humans is S4185 (the numbering system used in
this work is based on the canonical human titin sequence
UniProtKB Q8WZ42-1), which is also a residue phosphor-
ylated by PKA (20,21). More recently, it was discovered
that the N2B element of cardiac titin is a target of
calcium/calmodulin-dependent protein kinase II delta
(CaMKIId) (21,22). CaMKIId is the predominant CaMKII
isoform in the heart (23), where it phosphorylates severalhttp://dx.doi.org/10.1016/j.bpj.2015.11.002
Phosphorylating Titin Lowers Passive Force 2593Ca2þ-handling proteins, including phospholamban (PLB)
(24), ryanodine receptor (RyR2) (25), and L-type Ca2þ
channel (LTCC) (26), as well as the myofilament proteins
TnT (27) and MyBP-C (28). We previously showed that
phosphorylation of titin by CaMKIId occurs in vivo,
including during ischemia/reperfusion (IR) injury, which
is known to activate CaMKIId (29). IR injury induces an in-
crease in the phosphorylation level of CaMKIId sites on ti-
tin, and this is abolished by the CaMKIId inhibitor KN-93
(22). There are nine serine and threonine residues in the
N2B-Us that are phosphorylated by CaMKIId (21,22).
Two of these sites (S3750 and S4209) are highly conserved
among mammals, suggesting their importance in the regula-
tion of titin’s elastic properties (11,12). Another kinase that
was recently shown to target sites located in the N2B-Us of
titin is extracellular signal-regulated kinase 2 (ERK2) (30).
ERK2 phosphorylates three serines in titin’s N2B-Us:
S3918, S3960, and S4010 (the latter of which is well
conserved) (11,30). It has been proposed that ERK2-based
phosphorylation lowers titin-based passive tension (30),
but experimental evidence for this proposal is lacking. In
this work, we used single-molecule force spectroscopy
(31) to examine the effect of CaMKIId and ERK2 phosphor-
ylation on single-molecule mechanics, which has not been
studied before. We also examined muscle mechanics (32)
and studied the effects of CaMKIId and ERK2 on passivestress using a repeated stretch-release protocol that mimics
the heart cycle.MATERIALS AND METHODS
Protein constructs
Two different recombinant protein constructs were used in this study. The
first consisted of the entire human titin exon 49 sequence (I24–I26),
N2B-Us, and intermediate unique sequences (Fig. 1 A). The sequence
was amplified by PCR from total human cDNAs, and primer pairs were
derived from the human cardiac titin N2B isoform. The pETM-11 con-
structs were transformed into BL21(DE3) pLysS cells, and isopropyl
b-D-1-thiogalactopyranoside (IPTG)-induced proteins were purified from
the soluble fraction on Ni2þ-nitrilotriacetic acid (NiNTA) columns (taking
advantage of the N-terminal 6XHis tag provided by the vector), quick-
frozen, and stored at 80C until later use. The second construct was a
modified version and contained only the N2B-Us flanked by two I24 do-
mains on either side, with no unique sequences in between (see Fig. 5 A).
The expression construct (synthesized by DNA2.0) had the IPTG-inducible
pJexpress vector backbone and included an N-terminal 6XHis-tag and two
cysteine residues at the C-terminus to aid in attachment to gold-coated sub-
strates. The induced protein was purified on NiNTA columns, quick-frozen,
and stored at 80C until later use. The purified proteins were then either
phosphorylated with ERK2 or CaMKIId, or left unphosphorylated to serve
as controls. To determine the optimum phosphorylation level of the N2B-
Us, various concentrations of CaMKIId were used, followed by analysis
using a 10% SDS-PAGE and a Pro Q-Diamond phospho-stain. The gel
was then stained with Coomassie blue (CB) to determine the total protein
content. The CB stain was used to normalize the Pro-Q diamond signal.FIGURE 1 Single-molecule mechanics on titin’s
N2B element. (A) Schematic of an N2B molecule
tethered between a microscope slide and cantilever
tip. (B) Example of a force-extension curve of the
N2B molecule. Three force peaks are present due
to Ig domain unfolding, and a fourth peak repre-
sents the molecule breaking loose from the canti-
lever. Force curves were fit by the WLC
equation; contour length (Lc) values are shown in
the inset. The Lc of the first peak is due to the
N2B-Us, and the subsequent Lc values indicate
gains due to Ig domain unfolding. (C) Lc histogram
of N2B-US. (D) Persistence length (Lp) histogram
of N2B-Us. (E) Unfolding force (Uf) of Ig do-
mains. Results were fit by Gaussian curves; peaks
are shown on the graph. To see this figure in color,
go online.
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concentration of 0.075 U/mL maximally phosphorylated the N2B recombi-
nant protein. For ERK2 phosphorylation, the level was determined to be
1.5 U/mL (Fig. 2 B). Aliquots of the protein were frozen at 80C. For
each experiment, one aliquot of protein was thawed and incubated on a
glass slide in a buffer solution (25 mM BES, 2.5 mM EGTA, 1.5 mM
MgCl2, 1.25 mM NaATP, 165 mM KCl, 5 mM dithiothreitol (DTT; omitted
for the experiments under oxidizing conditions), pH 7.0). The concentration
of recombinant protein in buffer solution was ~0.5 nM. The reducing agent
DTT (1 mM) was added fresh to prevent the formation of disulfide bridges
within the N2B unique sequence, but in other experiments DTTwas omitted
so that the effect of disulfide cross-links on the mechanical properties of the
N2B molecule could be studied (33).Single-molecule force spectroscopy
An MFP3D atomic force microscope (Asylum Research, Santa Barbara,
CA) was used for force spectroscopy. To determine the spring constant of
the cantilever (model MLCT; Bruker), a thermal calibration was conducted
(typical values were 15–25 pN/nm). After the calibration, the cantilever tip
was used to probe the surface of the gold-coated glass slide. The piezo mo-
tor moved the cantilever up and down, and was set to operate at a pulling
velocity of 1000 nm/s. The cantilever tip approached and retracted from
the surface of the slide, and when an extension/retraction force curve was
obtained, it was evaluated as to whether it displayed a low-force region
(extension of the N2B-Us) followed by several regularly spaced (~30 nm)
sawtooth force peaks (one for each Ig domain present) and one final
larger-force detachment peak (Fig. 1 B). Curves were analyzed using the
wormlike-chain (WLC) equation (34,35):
F ¼ kBT
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0
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where F is the force, kBT is the thermal energy (kB is Boltzmann’s constant
and T is the absolute temperature), Lp is the persistence length of themolecule, Lc is the contour length, and z is the end-to-end length of
the molecule. The Lp is the minimal distance along the backbone of the
molecule over which tangent lines are correlated, or, in other words, Lp
describes the inverse of the propensity of the molecule to collapse. An in-
crease in Lp after phosphorylation effectively means that the molecule ex-
tends more for the same force. At the cardiac myocyte level, thisBiophysical Journal 109(12) 2592–2601corresponds to a more compliant myocardium. Most curves had a smooth
initial low force-extension phase, but some had small force peaks at
several tens of piconewtons. The results of these curves were grouped
with those for the rest of the molecules in which such small force bumps
were absent.Skinned muscle mechanics
Papillary muscles were harvested from 3-month-old female mice on a
C57BL/6 background. All experiments were performed in accordance
with the NIH Guide for the Care and Use of Laboratory Animals and
approved by the IACUC of the University of Arizona. Muscle preparations
were dissected as previously described (36). The skinned muscle was
treated with 0.5 U/mL protein phosphatase 1 (recombinant rabbit muscle
a-isoform; Calbiochem) for 2 h and then washed extensively in relaxing so-
lution. Fiber bundles were secured to a servo-motor (308B; Aurora) and
force transducer (AE801; SensorOne) on either end with aluminum T-clips
in a bath of relaxing solution. Tension and sarcomere length (SL) were re-
corded simultaneously with the force transducer and a laser diffraction sys-
tem with a spatial resolution of ~10 nm/sarcomere and a time solution of
2 ms. Muscle bundles were set to slack SL (defined as SL with zero passive
stress). We determined the slack SL by shortening the passive muscle until
it clearly buckled, holding it there for 10 min, and then stretching the mus-
cle to the minimum length at which the buckle was taken up and no detect-
able passive force developed, at which point we measured the SL by laser
diffraction (~1.85–1.9 mm). We used the active tension as a measure of tis-
sue health by activating the skinned fibers with pCa 4.0 activating solution
(36) (typical values were 30–40 mN/mm2). After the slack length was deter-
mined and the tissue was activated and relaxed, it underwent a series of tan-
dem triangle stretches from slack to an SL of 2.2 mm at 300%/s for 1000
cycles. (The stretch speed and maximal SL approximate the physiological
conditions during diastole (37).) The solution in the bath was then replaced
with relaxing solution containing kinases with and without kinase inhibitors
(for the control experiment). In the CaMKIId study, preactivated CaMKIId
(0.26 U/mL, recombinant human; Life Technologies) was added in the
absence or presence of 0.06 mM Autocamtide-2-Related Inhibitory Peptide
II (AIP-II; Calbiochem). Similarly, for the Erk2 study, the solution con-
tained 31.2 U/mL Erk2 (recombinant human; Calbiochem) in the absence
or presence of 0.14 mMErk Inhibitor II (FR180204; Calbiochem). The fiber
bundle was incubated at room temperature in the kinase/inhibitor solution
for 3 h (to ensure optimal phosphorylation), with a stretch to an SL of
2.1 mm every 5 min. Finally, the bundle was thoroughly washed with relax-
ing solution before the same series of stretch/release cycles described above
was repeated.FIGURE 2 (A and B) The N2B element is a
CaMKIId (A) and ERK2 substrate (B). Top:
in vitro kinase assays with the protein gel stained
by Coomassie blue (left) and the corresponding
ProQ Diamond phospho-stained image (right).
Bottom: phosphorylation level (ProQ/Coomassie)
versus kinase concentration.
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The force-SL relation of a single titin molecule (N2B cardiac titin isoform)
was calculated using the WLC equation (38), with three serially linked
WLCs representing the combined proximal and distal tandem Ig segments,
the PEVK, and N2B-Us spring elements (39). The Lc of the tandem Ig seg-
ments was 200 nm (40 Ig domains with an average spacing of 5 nm). The
PEVK Lc was 70 nm and the N2B-Us Lc was 180 nm. The Lp values were
12 nm (tandem Ig segments), 1.0 nm (PEVK), 0.3 nm (dephosphorylated
N2B-Us), and 0.6 (phosphorylated N2B-Us). (For experimental evidence
that underlies these values and additional details, see previous studies
(39–42) and Results. Note that for simplicity’s sake, the simulation does
not take into account the bimodal Lp distribution that was found.) The
force-SL relation of a single titin molecule was then calculated and the re-
sults were compared for phosphorylated molecules and molecules with de-
phosphorylated N2B-Us (see Fig. 7 A). At an SL of 2.2 mm (selected
because at this length the fractional extension of the N2B element is
>0.1, which avoids volume-exclusion and self-interaction effects (34,35),
and this SL is near the upper limit of the physiological SL range), the force
difference due to N2B-Us phosphorylation was calculated and compared
with the tissue-mechanics results.Statistical analysis
The effects of phosphorylation on the Lp, Lc, and unfolding force (Uf) were
analyzed using a two-tailed t-test, and p < 0.05 was taken as significant.
(The same results were obtained when a nonparametric Mann-Whitney
test was used.) Values were also plotted in histograms that were fit with
Gaussian curves (GraphPad Prism). For the skinned-muscle data, mean
and SEM force values were calculated at each cycle number (see Fig. 6)
and results were fit with a two-phase-decay equation. A statistical analysis
was performed (GraphPad Prism) to test whether the two data sets (results
after kinase treatment and after kinase þ inhibitor treatment) were best fit
by one or two equations (see Fig. 6). A nonlinear regression was performed
with an extra sum-of-squares F test to determine whether there was
evidence that the data sets differed from each other. The simpler model
(i.e., single equation) was preferred for p-values > 0.05.FIGURE 3 (A and B) Effect of CaMKIId (A) and ERK2 (B) on the Lp
of N2B-Us. After phosphorylation, the Lp distribution is shifted to the
right from that of unphosphorylated molecules (indicated by broken
curves; same data as in Fig. 1). The values shown are peak positions of
Gaussian fits.RESULTS
Single-molecule force spectroscopy
Titin’s N2B element is a cardiac-specific spring that func-
tions as a phosphorylation hotspot, and we investigated
the effects of CaMKIId and ERK2 using single-molecule
force spectroscopy and tissue mechanics. Fig. 1 A shows a
schematic of an N2B molecule tethered between a micro-
scope slide and cantilever tip. The native N2B element con-
sists of a large unique sequence (N2B-Us, 575 residues)
flanked at one end by I26 and at the other by I24 and I25
(separated by a short 21-residue unique sequence) and a ter-
minal 67-residue unique sequence. An example of a force-
extension curve is depicted in Fig. 1 B. There is an initial
low-force phase (due to extension of the N2B-Us) followed
by three force peaks (due to Ig domain unfolding), and a
fourth peak representing the molecule breaking loose from
the cantilever. Force curves were fit by using the WLC equa-
tion (broken lines in Fig. 1 B) and the Lc and Lp were deter-
mined. The mean Lc data are shown in the inset of Fig. 1 B.
The Lc of the first peak (~180 nm) and the subsequent Lc
gain (~35 nm) are likely due to the N2B-Us and Ig domainunfolding, respectively. The Lc histogram of the N2B-Us is
fairly broad (Fig. 1 C) and can be fitted with a single
Gaussian with a maximum at 181 nm. The Lp distribution
of the N2B-Us ranges from ~0.2 to ~0.8 nm and can be fit
with a single Gaussian curve (broken curve in Fig. 1 D)
or, with a slightly better r2, by the sum of two Gaussians,
with a main peak at 0.27 nm (solid curve in Fig. 1 D).
The Ig domain Uf histogram (all values were grouped)
ranged from ~100 to 300 pN, with a Gaussian curve fit
that had a maximum at 174 pN (Fig. 1 E). Thus, force spec-
troscopy on the N2B molecule makes it possible to charac-
terize the properties of the N2B-Us and examine how it is
affected by phosphorylation.Effect of CaMKIId and ERK2 on N2B-Us
In vitro kinase assays showed that the N2B element is a
good substrate for both kinases (Fig. 2), confirming earlier
findings (21,22,30).
Force spectroscopy on phosphorylated molecules did not
reveal any easily detectable change, but when N2B-Us Lp
values were plotted in a histogram, a shift to larger values
became apparent in both CaMKIId- and ERK2-treated sam-
ples (Fig. 3). ERK2 data were fit best by the sum of two
Gaussians with peaks at 0.36 and 0.67 nm, and CaMKIId
data were fit best by a single Gaussian phosphorylated
with a peak at 0.48 nm. The bimodal distribution of the
ERK2 data set might reflect incomplete phosphorylation
or the presence of more than one phosphorylation site. A
comparison of the unphosphorylated and phosphorylated
data sets revealed a significantly increased Lp in ERK2
and CaMKIId. No differences were observed for Uf values
(Table 1). We noted a reduction in Lc values after phosphor-
ylation, which possibly reflects the formation of phosphory-
lation-induced stable structures, but the Lc reduction was
not statistically significant and thus might also be a random
effect.Biophysical Journal 109(12) 2592–2601
TABLE 1 Effect of CaMKIId and ERK2 on Single N2B Molecule Characteristics
I24–I26 N2B Control CamKIId ERK2
Lp, nm 0.375 0.02 (n ¼ 53) 0.475 0.02* (n ¼ 53) 0.475 0.03* (n ¼ 50)
Lc, nm 1895 7 (n ¼ 53) 1715 10 (n ¼ 53) 1725 7 (n ¼ 50)
Uf, pN 1735 9 (n ¼ 112) 1745 9 (n ¼ 96) 1635 6 (n ¼ 107)
(I24)x4 N2B Control CaMKIId
Lp, nm 0.255 0.03 (n ¼ 36) 0.475 0.06** (n ¼ 33)
Lc, nm 1955 7 (n ¼ 53) 1805 6 (n ¼ 33)
Uf, pN 1735 5 (n ¼ 114) 1525 7* (n ¼ 109)
Lp, persistence length; Lc, contour length; Uf, unfolding force.
*p < 0.05.
**p < 0.01.
2596 Perkin et al.Considering that the native N2B molecule also has small
unique sequences flanking I24 (21 and 67 residues, respec-
tively) that potentially contain phosphorylation sites, we
sought to determine for both ERK2 and CaMKIId whether
the phosphorylation effect was indeed due to the large
unique N2B-Us sequence. For ERK2, we followed up on
work by Leake et al. (33), who performed experiments un-
der oxidizing conditions and showed that the N2B-Us forms
disulfide cross-links. The N2B-Us contains six cysteines,
and all possible cross-link combinations and how they
reduce Lc are shown in Fig. 4 A. (Cysteines are absent
from the short unique sequences that flank I24.) The notion
that cross-linking occurs in the N2B-Us is supported by a
previous study in which oxidizing conditions resulted in
an increase in passive stiffness in skinned muscle from
wild-type mice, but not in mice from which the N2B-Us
had been deleted (32). In this study, we found that the
measured Lc histogram of the N2B-Us under oxidizing con-
ditions was distinct from that obtained in the presence of
DTT. The distribution was bimodal with a major peak atBiophysical Journal 109(12) 2592–2601107 nm and a minor peak at 195 nm (Fig. 4 B). Since the
latter peak overlaps that of the Lc measured with DTT (re-
produced in Fig. 4 B by the broken curve), it is likely that
this reflects the uncross-linked N2B-Us and the peak at
the shorter-length cross-linked N2B-Us. Thus, cross-linking
shortened the Lc of a large fraction of the molecules by
~90 nm. This value is consistent with cross-links between
cysteines 1 and 3, and cysteines 2 and 4 (Fig. 4 A, right).
Since this hides ERK phospho-sites (two of the three sites
for one to three cross-links, and all three sites for two to
four cross-links), the effect of ERK2 phosphorylation under
oxidizing conditions was studied. No ERK2 effect was
found (compare Fig. 4, C and D). This supports the notion
that the ERK2 effect on Lp measured under reducing condi-
tions is due to phosphorylating N2B-Us.
To test whether the CaMKIId effect was based on phos-
phorylation of only the N2B-Us or involved any of the other
unique sequences (flanking I24), we studied a construct that
consisted of the N2B-Us with two flanking I24 domains
((I24)x4-N2B-Us; Fig. 5 A) on either side. (Note thatFIGURE 4 Effect of ERK2 on N2B-Us measured
under oxidizing conditions. (A) Left: N2B-Us with
its six cysteines (red font) and the three ERK2 phos-
pho-sites (blue font). Right: all possible cross-link
combinations between the six cysteines, showing
the number of residues in between the cross-links
and the effect of cross-linking on the Lc of the
N2B-Us (shown in parentheses and calculated
assuming that each reduces the Lc by 0.35 nm).
(B–D) Measurements obtained under oxidizing
conditions (no DTT). (B) Lc of N2B-Us. The Lc
distribution can be fit with a double Gaussian with
peaks at 107 and 195 nm. Broken curve: measure-
ments under reducing conditions (from Fig. 1 B).
The difference in peak positions (88 nm) can be ex-
plained by cross-linking between either the first and
third or the second and fourth cysteines (indicated
in red in (A), right). (C and D) ERK2 has no effect
on the Lp. To see this figure in color, go online.
FIGURE 5 Effect of CaMKIId on the single-
molecule mechanics of (I24)x4-N2B-Us molecules.
(A) The N2B molecule consists of a large unique
sequence (N2B-Us) flanked at both ends by two
identical I24 domains. (B and C) Lp (left) and Uf
(right) distribution of unphosphorylated molecules
(top: control; bottom: CaMKIId phosphorylated).
To see this figure in color, go online.
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good option for CaMKIId because there are many phos-
pho-sites (12), including outside the cysteine-containing re-
gion of the N2B-Us.) The N2B-Us Lp and Uf of the
unphosphorylated (I24)x4-N2B-Us molecules were indis-
tinguishable from those of the native N2B molecule
(Fig. 5 B and Table 1, bottom). After CaMKIId phosphory-
lation, the Lp distribution was bimodal, with a new peak at
0.66 nm (Fig. 5 C, left), and when analyzed by t-test, Lp was
found to be increased relative to unphosphorylated mole-
cules (Table 1, bottom). The N2B-Us Lc was unchanged,
but, interestingly, the average Uf was slightly but signifi-
cantly reduced (Fig. 5 C, right). It is possible that coupling
between the N2B-Us and I24 somehow caused the reduction
in Uf. Alternatively, it is possible that I24 became phosphor-
ylated and this reduced the Uf. The fact that this effect was
not seen in the I24-I26-N2B-Us construct suggests that I25
and I26 were unchanged and dominated the histogram of all
unfolding events. In summary, the studies on the (I24)x4-
N2B-Us construct show that the effect of CaMKIId phos-
phorylation on the N2B element does not rely on the small
unique sequences that flank the native I24.Effect of CaMKIId and ERK2 on the passive force
of skinned cardiac muscle
To determine whether our single-molecule findings have
relevance for muscle, we performed mechanical experi-
ments on passive skinned myocardium. We used a cyclic
stretch/release protocol that mimics loading conditions in
the heart (see Materials and Methods). For each cycle, pas-
sive stress (force per unit area) was measured at the peak of
the stretch (SL 2.2 mm). All muscles were studied before
and after they were incubated with kinase. In control exper-
iments, muscles were treated the same except that in addi-
tion to kinase, a kinase inhibitor was added (see Materialsand Methods), yielding two data sets (kinase and kinase þ
inhibitor). There was significantly less passive stress in mus-
cles that were treated with kinase (compared with kinase þ
inhibitor), supporting the notion that passive stress is
reduced by phosphorylation (Fig. 6, A–C). However, the
percent stress reduction was much larger for CaMKIId
than for ERK2 (Fig. 6 D). To ensure that the ERK2 treat-
ment resulted in titin phosphorylation (it is known that
CaMKIId phosphorylates titin in skinned muscle (21,22)),
we performed ERK2 phosphorylation assays on skinned
muscle. These assays showed robust phosphorylation of titin
(Fig. 6, top right).
To gain insights into whether the large CaMKIId passive
stress reduction (~30%) or the small ERK2 reduction (~6%)
was in line with the single-molecule studies, we performed
simulation experiments. Titin’s spring region consists of
three serially linked spring elements, and we calculated
the predicted force-SL relation of a single titin molecule us-
ing a serially linked WLC model with an Lp of 0.3 for un-
phosphorylated N2B-Us and 0.6 nm for phosphorylated
molecules (other Lc and Lp values and additional details
are given in Materials and Methods). (Note that for
simplicity, the multimodal distribution of Lp values was
not incorporated into the simulation.) The results indicate
that the predicted force was reduced in the phosphorylated
state (Fig. 7), e.g., at SL 2.2 mm, the predicted force reduc-
tion was 25%.DISCUSSION
Posttranslational modifications of titin’s spring region are
important for tuning passive myocardial stiffness and are
likely to play an important role in the diastolic dysfunction
that characterizes heart-failure patients. Here, we studied ti-
tin’s N2B element, a cardiac-specific spring that functions
as a phosphorylation hotspot, and investigated the effectsBiophysical Journal 109(12) 2592–2601
FIGURE 6 Effect of CaMKIId (left) and ERK2
(right) on the passive stress of skinned myocar-
dium. Passive muscle was stretched in a cyclic
manner from slack SL to an SL of 2.2 mm, followed
by a release back to slack, and the peak stress was
plotted versus the cycle number. (A–C) Results
before (A) and after (B) incubation in kinase or
kinase þ inhibitor, and (C) the magnitude of stress
reduction. Right: the top inset shows the effect of
ERK2 on titin phosphorylation. (D) Left: percent
reduction due to CaMKIId phosphorylation
((before  after)/before  100%, corrected for a
reduction in CaMKIId þ inhibitor). Right: the
same as at left, but for ERK2. The percent reduc-
tion is much larger for CaMKIId than for ERK2.
See Materials and Methods for additional details.
FIGURE 7 Measured and predicted effects of increasing the Lp of N2B-
Us on passive force. The predicted force-SL relation of a single titin mole-
cule was calculated using a serially linked WLC model with an N2B-Us Lp
of 0.3 nm (unphosphorylated state) or 0.6 nm (phosphorylated state). (For
other parameters and additional details, see Materials and Methods.) The
predicted force is reduced in the phosphorylated state. The percent force
reduction is shown as a function of SL in the inset. The measured force
reduction at SL 2.2 mm after CaMKIId and ERK2 phosphorylation (data
from Fig. 6 D) is also shown. The magnitude of the measured force reduc-
tion after CaMKIId phosphorylation is similar to the predicted value, but
the measured ERK2 phosphorylation is considerably less than predicted.
2598 Perkin et al.of CaMKIId and ERK2 using single-molecule force spec-
troscopy and tissue mechanics. We found that both
kinases increased the Lp of the N2B element and that this
effect required the large unique sequence, the N2B-Us.
Tissue mechanics revealed that in line with the measured
Lp change, passive myocardial stress was reduced, but
the effect was much larger for CaMKIId than for ERK2.
Below, we discuss these findings and their functional
implications.
The Lp distribution of the N2B-Us shifted to larger values
after phosphorylation by CaMKIId or ERK2 and the histo-
grams showed subpeaks, likely due to a subpopulation of
unphosphorylated molecules combined with those that had
been phosphorylated. The various Lp histograms that were
obtained suggest that phosphorylation increased the Lp
from ~0.3 to ~0.6 nm. These values can be compared with
those obtained by Kruger al. (20), who studied the effect
of PKG, which targets S4185 near the C-terminus of the
N2B-Us, a residue that is also phosphorylated by PKA. In
line with our findings, PKG phosphorylation was shown to
increase the Lp from 0.31 to 0.67 nm (20). It is currently un-
known how phosphorylation increases the Lp. It is possible
that changes in the bending rigidity of the N2B-Us are due
to the addition of negative charges and/or the existence of
local structures that undergo structural transitions when
phosphorylated. This important issue needs to be experi-
mentally addressed in future work using structural tech-
niques such as circular dichroism and Fo¨rster resonance
energy transfer. In summary, together with earlier findings,
our results suggest that phosphorylating the N2B-UsBiophysical Journal 109(12) 2592–2601sequence increases Lp irrespective of the phosphorylation
sites involved.
An increase in Lp at the single-molecule level is predicted
to lower the passive force of the cardiac myocyte (Lp and
force are inversely related), and we tested this prediction
in mechanical studies on mouse papillary muscle. In
these studies, we used a repeated stretch-release protocol
that mimicked the physiological strain rate in the heart.
We noted that passive force revealed a time-dependent
Phosphorylating Titin Lowers Passive Force 2599exponential decline. These protocols started with a well-
rested skinned muscle held at its slack length. We propose
that in that state, nonspecific interactions form (e.g., electro-
static interactions between oppositely charged protein do-
mains), either within subdomains of titin or between titin
and other filaments. Such bonds will impede titin stretch,
and thus during a repeated stretch-release protocol, the pas-
sive force will initially be high. However, the bonds are ex-
pected to break during stretch (progressively more of them
as the number of stretch/release cycles increases), and
consequently the force will progressively decline (only dur-
ing a prolonged rest at the slack length will the bonds re-
form). We obtained evidence for such a mechanism in
single-molecule experiments in which titin was repeatedly
stretched (43). We determined the predicted effect by using
a serially linked WLC model in which the three spring ele-
ments within titin’s extensible region (tandem Ig segments,
the PEVK, and the N2B-Us) were linked and the Lp of the
N2B-Us was varied from 0.3 nm (unphosphorylated) to
0.6 nm (phosphorylated). The obtained force reductions
increased with SL (the N2B-Us becomes progressively
more important to titin’s elasticity as the sarcomeres are
stretched (41,44)), e.g., at an SL of 2.0 mm the predicted
force reduction was 7%, whereas at 2.2 mm it was 25%.
Phosphorylating skinned muscle with ERK2 resulted in
only a small passive force reduction, ~6%, which is much
less than predicted. Although titin was robustly phosphory-
lated when skinned muscle was exposed to ERK2 (Fig. 6,
top right), we cannot firmly exclude the possibility that
some ERK2 phosphorylation sites are not accessible due
to the recently reported interaction between four-and-a-
half lim (FHL) protein and the N2B-Us that inhibits
ERK2 phosphorylation (30). Alternatively, since for sin-
gle-molecule force spectroscopy we used an N2B construct
that was based on a human sequence, but used mouse mus-
cle to investigate tissue mechanics (human tissue was un-
available), it is also possible that the limited evolutionary
conservation of the ERK2 sites (11) plays a role. Finally,
it is worth noting that even modest changes in passive stiff-
ness are likely to be functionally relevant, especially at high
heart rates where filling times are short.
In contrast to the ERK2 effect, an ~30% reduction in
force (SL 2.2 mm) was observed in CaMKIId-treated
myocardium, a value that exceeds the predicted 25%.
Considering the uncertainty in some of the single-molecule
simulation parameters and the various sources for measure-
ment error, both in single-molecule force spectroscopy and
in muscle mechanics, the predicted and measured values
(for CaMKIId) are quite close. It is also worth noting that
CaMKIId phosphorylates not only the N2B-Us but also
various other sites within titin (12). Of particular interest
are two residues within the PEVK spring element, S11878
and S12022 (22), which when phosphorylated increase pas-
sive force (45,46). The large reduction in measured passive
force clearly indicates that the N2B-Us sites dominate,which is consistent with earlier findings (22). Our muscle-
mechanics results can be compared with those of Hamdani
et al. (21), who measured the effect of CaMKIId on passive
force in skinned cardiac myocytes from mice and found re-
ductions of ~45% at an SL of 2.2 mm, which is greater than
the values measured in this study. A possible explanation is
that we performed control studies in the presence of
CaMKIId and its inhibitor (which is needed because the me-
chanical protocol is demanding and requires long incubation
times, which is likely to cause rundown, e.g., due to prote-
olysis or protein extraction). An interesting possibility is
that the unfolding of Ig domains contributes to the force
reduction, since we found that in the (I24)x4-N2B-Us
construct Uf values were reduced after CaMKIId treatment
(Fig. 5 C, right), and there is also evidence for phosphoryla-
tion by CaMKIId of various other I-band Ig domains (21). If
Ig domain phosphorylation lowers the Uf, this could also
cause a reduction in passive force that would add to the
reduction that originates from the N2B element. In sum-
mary, both our studies and those of others have found robust
passive force reductions after CaMKIId phosphorylation.
The results from single-molecule force spectroscopy sug-
gest that a large part of this reduction is readily explained
by the increased Lp of titin’s N2B-Us.Physiological relevance
CaMKIId is the predominant CaMKII isoform in the heart,
where it phosphorylates several Ca2þ-handling proteins
(23), as well as myofilament proteins (27,28). Phosphoryla-
tion of titin by CaMKIId has been shown to occur in vivo
under several conditions, including IR injury, a pathological
state that is characterized by elevated CaMKIId activity and
calcium overload (29,47). Recently, it was shown that IR
injury induces an increase in the phosphorylation level of
CaMKIId sites on titin, which is abolished by the CaMKIId
inhibitor KN-93 (22). The work presented here predicts that
in IR injury, CaMKIId-induced phosphorylation of titin will
lower passive stiffness. We propose that this is a beneficial
adaptation that offsets increased passive stiffness due to
the known effects of calcium overload on actomyosin inter-
action (47). It is interesting that one of the functions of
CaMKIId is to regulate frequency-dependent acceleration
of relaxation (23,48) by phosphorylating PLB and promot-
ing Ca2þ reuptake from the cytosol by SERCA, thereby
maintaining efficient ventricular filling at high heart rates.
Phosphorylation of the N2B element by CaMKIId and the
ensuing decrease in titin-based passive stiffness are ex-
pected to further augment ventricular filling. Thus, it is
likely that phosphorylation of titin by CaMKIId helps to
maintain diastolic function at high heart rates. Finally, phos-
phorylation of histone deacetylases by CaMKII results in
cardiac hypertrophy and remodeling (49), and it has been
suggested that CaMKII inhibition may be a therapeutic op-
tion to treat chronic overload-induced heart disease (50).Biophysical Journal 109(12) 2592–2601
2600 Perkin et al.Our work suggests that this should be done with caution,
however, considering that this will abolish the beneficial ef-
fect of titin on diastolic function.
ERK2 is part of the mitogen-activated protein kinase
signaling cascade (Raf1/Mek2/Erk2) with multiple down-
stream signaling pathways that play an important role in
regulating cardiac hypertrophy and remodeling (51–53).
Our work confirms the recent finding that ERK2 phosphor-
ylates titin (30), and for the first time (to our knowledge)
shows that this increases the Lp of single molecules of titin
and (modestly) lowers passive stiffness in muscle. Interest-
ingly, FHL1 and FHL2 bind the N2B-Us (30,54,55) near the
ERK2 phospho-sites (30), and, importantly, binding inter-
feres in a dose-dependent manner with ERK2-mediated
N2B-Us phosphorylation (30). Thus, passive stiffness can
be regulated by ERK2 activity and by regulating the avail-
ability of ERK2 phospho-sites on titin. Finally, since FHL
proteins are upregulated in pressure, and volume overload
induces hypertrophy (56–58), the potential for dysregulated
ERK2 phosphorylation exists in these pathological states.
In conclusion, the important kinases ERK2 and CaMKIId
regulate passive force by increasing the bending rigidity of
the cardiac-specific N2B element. Although the in vivo rele-
vance of these important findings requires further study,
ERK2 and CaMKIId are likely to have a beneficial effect
during conditions of stress when they become activated
and the effects can be countered by stress-response proteins
that bind to titin’s N2B element.AUTHOR CONTRIBUTIONS
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